Plus Therapeutics Announces Participation at Upcoming SNO Pediatric Conference and SNMMI Annual Meeting

Author's Avatar
Jun 08, 2023

Company to showcase pipeline developments across lead programs in recurrent glioblastoma and leptomeningeal metastases in two poster presentations at SNMMI Annual Meeting